Form 4 holding
Interim Chief Financial Officer & Controller
BRAINSTORM CELL THERAPEUTICS INC.
- Security class
- Common Stock
- Shares / value
- 144,349
- Estimated value
- $10,112
- Report date
- 26 Feb 2026
- Price
- $0.2280
- Ownership
- Direct